New Delhi: The technical advisory group of the World Health Organisation (WHO) will meet on October 26 to consider emergency use listing (EUL) for Bharat Biotech’s COVID-19 vaccine Covaxin, WHO’s chief scientist Soumya Swaminathan informed on Sunday.Also Read - I'm Sure WHO Approval For Covaxin Will Come as Soon as Possible: Foreign Secretary

“The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere,” Swaminathan tweeted. Also Read - Final Approval of Covaxin For Children Under Evaluation, Biological E To Submit Data By Nov-End: Report

Also Read - Covaxin For Kids in India: How Many Doses to Take, What Does 'Restricted Usage' Mean, Booster Dose - All You Need to Know

The Strategic Advisory Group of Experts on Immunization (SAGE) of the WHO which held a meeting on October 6 to make its recommendations on Covaxin on EUL, among other issues, had earlier said it will take a call on granting EUL status to Covaxin in a week’s time.

The EUL process being carried out by the WHO and the Technical Advisory Group of independent experts – is centered on determining if a manufactured product such as vaccine is quality-assured, safe and effective, WHO earlier said.

The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is October 2021 according to the update available on the WHO website.

Covaxin is one of the three vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

(With inputs from PTI)